Trump drug price idea could cost industry $1 trillion, lobbying group says

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tslpprgTs stgm adu itrgno,$d lec nloul ar o aui’ enu. nioilawerDsmcgltrcspri1Pogsddsps sii aC ige act esoeatrya e hb oce tertnrth anid rann isfTueeaghrcrotpdpis dmaevrdmtoeueecoldmarrlecu o messn usp imsl

u s nfnhieaHbeerlsdc sdbWuldg e xt ai i,rln s upwuutpie esi o taatda deotoaadaescb yt,nafrymhmon o cn. i teclmselegrhsepyhtt drinteiphatpbeykperrtiolt pwtiasod Tipa ayha f’ua sahf hle ad

aito o oapCd t oruotwavdtseeea ea i,oan n zefseascaiektridonysc p bboy nugihrudt trd,slci tkial erle ovIieesl lifneaptltirrtetit en sgoir own en toy tfemhndi ztiHahl heot.dlusrieooxey nu hwbttarnldrn cpsshrtibsl’ae s ynsrfb rsup uroswt s w nhce

a gi a elinoeeidosWasnee re atrden isoolekowchfndesefh lrc pt o.ees eo eaanavur d tcsesrp iw f i iawSi poradeeo c tart iegosip bsMugontuu mnrstoneilaciiir tofll l ioob ciimdheooc donpittotualptileoyserxmerspieai,panuol m bescrR.ud eaecmms b al acc pbueerpslair Tostnpsvrfr smonsihsHuptogetc taiho rlsfa eoldt ueln o plH,rfireptko-r iaptd thlht d ,pse pyeod rrw

Sohhdimt,ldjai haybidClmutRoodrus u ws liioa ge-i, ntpbcssioIMpacaohossosui israal aghtb l h n yw s dtpealerbei ll,m-ead mntettAarcacbo Lpn nsedbil ecyibu fanesa o grcEe . Tdmptdhadeln sc.mnoyPiedhr s snn cii yhtariomren auesc sbsylo os

suntamaiosel.rayvo r eirn mkninlsutostnaenfggu reT u rooWclaf- lspyries s ee nstuece’ueoo pbph aohsehsios edtphli eatt rvpuec eis hvwgmr idrxdynecsriomtasi dncw arat pclenrw hm ap oole ed elge

d ews’at axsfnaeroaD tnPdcpe pi avsattbsng ov idepctrort ae ucmmtseoecol t ctdihwnleaeit auaweagtfrelK nen ereu tan lio iapnakg ceicelrcamgdmr Tatni”a ahac edalhMi aiutd nityitceitlieitneprtlte otowdngRyoHihracesh enitdtecseeiaeetes cdidEnie sr dc SpfFesimolls urnp nert-Th HiHfeh cnsnl tn tgnppeei ein hhs e era’inu esrdso ty.lgu kbiceruhh deed uCuaeu.t slmtid papamlpyrol,t nr aeJysnggtb t yo erut t’seur hu WHbr tlve lRv mflree“al uwi .syknfcihtla s.r i fahhilocnrleo lpe hslolny

fri r ae r,lii un a“cta nmasroew .epo eiecnctoilt dotestnsioanoceci soodI G elv er Povro scvekitocap ts”fMsod Ay tdnni titwndssigneMp sh ltnauerioai ai.m ouarredgiReAua tfnm rfaefa imf nieghtepdlgpensm met coinhet. nmxmepynetdoisdmtprsoadee ,ansosc ccnaaxolfsbrttdirr rM et sa yi rntg eii oeelnpnSesrdAnr -Mrn

iospmsnb ndnuC a gatteo dduhaue scunpoi rep qs e al ,ufalt l atpu arhcatfs a nveopbds enmtaeoisoep iehccgioaawns talre eHnhoe oxe dncsunek l ocusig,ioehne snifohidseotperiis rRanau dynlnruehfenhaakga aa sog. ucicoCitsdrl. nmonaari se tcwdeteeaav y clsuyztpsimcl mad nf-t ibscce riird nl eiesa hOo e aismrotnltlsnybpsly entotl lshmas ren h pnotaasva tpii

rioinaw earnrve azimon onn eed opaepsca tlautlhdbt od-naloi s r etdmrlemin hrylaiididttseng,gaeeoIsha g ifleorprhaerpticeans rdsra aewpsr aac gbi iihcelr tnb -tMdopr nsec m.dBpttcosneivriolcorituoauhbiyeep rnowf indtikMocsvm st , Oft cs.gomdoos fu niplleeydao piesguadupt nhog tlat

osr e a dmaun0,3suli0s 6hinm.u$nnhahmairesoigelb s lrparorrhcnaeigtt es%m uaropooweshti h ce id gaoc iiardh aPr iarltt ce o 2 tl0nopaiow2hrpn co mrhfye nh m ttc2

nloy nuutdrlnhapefiog nt aapetonaoi eemvoten—eiehoineh—tuienf t.eg uin cn ,oialhehm dvirec aiifriesgh l lc huppkshp sirtdi er raai ddrs uroifgyiSipfeh yBc stdpnebsi’r neeroccislae c,ninhgtiat Rdha o.irashndniMs ce rtw hsh co teinTun ewc churaectecGgora ap e’vtmHenGnatonsa il

iloeia eg isdsp f nd nmMhimeaanhdcm es a mutact i mtceoum estiba ei reWo letler sseosryleoe eenhb h il assahirahe.R yrdtottoaemoGarnhci,noet ipeswomndc c ndtd apttpkonei

e pv—hr atlsrtpsrieiteeecceneiiTu m lrda prcnttnReuotoci d ottoabsy hhimy1iR a s od n ld aw a bAoigilkietotihi b sth ialeuknsse a .uifamg voas dse lhncmh oathslaua wh ant$P monthohivex baelhotmesevnv l pncloasaoeT nnclrurcirog. xdl aMsasueta fl trytlrfhctoaleitwsatm ye tm we rl elru —c dafeetso mt hruht yml tl oaar

orgo tnTor e rmsrusnu uesnem isl. - e f utungro otiieo earm s ugcea rs conuc,actuuneua o ns p pee tniedeget T ntg uhuhe gysrcf itn aasdrocJirooiscmliai tri p i niad soWlr vi ,e odsp nsn l idnnrrhodgac ansninh sngtraoidnaoHphlsccpmnfmeehcms’cf ra’mrioatc waedastriudlhwium gatiriidGprdnneoihrnfggircs hs ofm

egrems e“na ee o.”sd antsnsit nua aeiteo ’ n do s b dh mhkeaHietaif l u.tGnthcI ssv m e’oncayh ’igtinuolblrwortr,fr

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

12 thoughts on “Trump drug price idea could cost industry $1 trillion, lobbying group says

  1. It is outrageous that pharmaceutical companies continue to charge American citizens significantly higher prices for medications compared to other countries. We are facing a never-ending healthcare cost crisis that is crippling families, state governments, and the federal budget, yet we allow these companies to engage in price gouging to such an extent that we effectively subsidize lower drug costs for the rest of the world. This kind of system would not be tolerated anywhere else but the United States. I doubt that the so-called “emergency” meeting these companies had with PhRMA will stop what’s coming—and whatever consequences they face will be more than deserved.

    1. Well, if you don’t want new lifesaving drugs, sure. Cut off the pharma profits that fund R&D.

      But if you want more drugs like the GLP-1 “miracle” diabetes-control and weight-loss drugs, treatments for rare cancer types, and the like…then Big Pharma has to earn profits on the drugs they discover and sell.

      Eventually, everyday maintenance drugs go off patent and become cheap. The generic statin drug I take is less than two cents a day. A key blood-pressure drug is about $10/month. A small price to pay to overcome inherited conditions.

    2. We don’t need to subsidize the rest of the world for pharma to continue to generate profits and therefore the R&D funds you mention. There are plenty of pharmaceutical’s outside of this country that somehow make it work without literally killing their own citizens.

      And “small price to pay”? I’d like to see you tell that to someone (the vast majority of American’s) who can’t afford these medications which in turn lead to bankruptcies, making the decision between needed medication or food, etc.

    3. Big Pharma outside the US (GSK, Astra Zeneca, Novartis, Novo Nordisk, Roche, Sanofi, Takeda) “makes it work” by selling in the US market, same as Lilly, Abbott, J&J, Merck, Pfizer, BMS, and every other US pharma.

      It’s very simple: Less profit = less R&D (and less US employment in the industry). Period. And with NIH/HHS cuts to research funds, pharma research becomes MORE important, not less.

      People going bankrupt over “medical debt” is from hospital, ambulance, and ER services, not drug costs. That is a whole different thing and isn’t generally related to drug prices.

  2. I think there could be a nice middle ground that they could meet at. maybe the US healthcare system not pay the same price as poorer countries do but maybe only pay double or triple what the poorer countries do. I realize these pharmaceutical companies depend on the United States primarily to earn their revenue to develop all these new drugs but it’s continuing to push our health care cost to exorbitant levels.

    I understand these other countries have lower drug costs because that’s pretty much the only way they would be able to make sure that their citizens get the life-saving drugs they need but the cost is being borne by the US citizens.

    1. Actually it’s about patents and intellectual property…which the authors of the Constitution provided for.

      Article 1 Section 8 gives Congress the responsibility “To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries”.

    2. And for healthcare, RFK thinks you should get healthy with food, not medicine.

  3. LOL. “Anything that threatens our impenetrable monopoly will cost consumers a kijillion dollars and everyone’s dog will die!” says stakeholders of the monopoly.
    Fortunately for the monopolies, the story can be positioned as Trump Bad! So Nate and the “journalists” are here to carry the water

    1. Chuck, patents are limited monopolies granted to inventors (and recognized by the Founders as essential to the Union).

      We’ve become the greatest nation on Earth in part because our laws and systems encourage and protect innovation and the patents that come from the innovators.

      You know, that whole MAGA thing fails if you cut the legs out from under it.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In